Treatment of Rivaroxaban versus Aspirin for Non-disabling Cerebrovascular Events (TRACE): study protocol for a randomized controlled trial

BACKGROUND: Transient ischemic attack (TIA) or minor ischemic stroke represents the largest group of cerebrovascular disease, and those patients have a high risk of early recurrent stroke. Over decades, anticoagulation therapy has been used prudently in them for likely increasing the risk of intra-/...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fang, Jiang, Wenrui, Bai, Ya, Han, Junliang, Liu, Xuedong, Zhang, Guangyun, Zhao, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603584/
https://www.ncbi.nlm.nih.gov/pubmed/26458895
http://dx.doi.org/10.1186/s12883-015-0453-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603584/
https://www.ncbi.nlm.nih.gov/pubmed/26458895
http://dx.doi.org/10.1186/s12883-015-0453-7

Ejemplares similares